Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
about
Interventions for fatigue in Parkinson's diseaseSide effects of a dopamine agonist therapy for Parkinson's disease: a mini-review of clinical pharmacologyWhat can rodent models tell us about apathy and associated neuropsychiatric symptoms in Parkinson's disease?Electroconvulsive therapy in Parkinson's diseaseMultivariate clustering of progression profiles reveals different depression patterns in prodromal Huntington disease.The Network Model of Depression as a Basis for New Therapeutic Strategies for Treating Major Depressive Disorder in Parkinson's DiseaseA systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015.A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.Nonergot dopamine-receptor agonists for treating Parkinson's disease - a network meta-analysis.The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's diseaseEfficacy of antidepressive medication for depression in Parkinson disease: a network meta-analysis.Parkinson's disease: the quintessential neuropsychiatric disorderSerotonin impairment in CSF of PD patients, without an apparent clinical counterpartA mouse model of non-motor symptoms in Parkinson's disease: focus on pharmacological interventions targeting affective dysfunctions.Course of psychiatric symptoms and global cognition in early Parkinson disease.Tricyclic antidepressants delay the need for dopaminergic therapy in early Parkinson's disease.Review: management of Parkinson's disease.Depression and Parkinson's disease: current knowledge.Treatment of cognitive, psychiatric, and affective disorders associated with Parkinson's disease.Managing depression in Parkinson's patients: risk factors and clinical pearls.A systematic review and meta-analysis of cognitive behavioral and psychodynamic therapy for depression in Parkinson's disease patients.Pramipexole for the treatment of early Parkinson's disease.Comparative efficacy and acceptability of antidepressants in Parkinson's disease: a network meta-analysisNoradrenaline and Parkinson's disease.Neurobiology of depression and anxiety in Parkinson's diseaseA meta-analysis of randomised placebo-controlled treatment trials for depression and anxiety in Parkinson's diseaseImpulse control disorders in Parkinson's disease: recent advancesCognitive-behavioral therapy for depression in Parkinson's disease: a randomized, controlled trial.Nonmotor outcomes in Parkinson's disease: is deep brain stimulation better than dopamine replacement therapy?Apathy and anhedonia in Parkinson's disease.Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunctionNeuropsychiatric symptoms in Alzheimer's diseaseHealth-related quality of life as an outcome variable in Parkinson's disease.Dyskinesias and treatment with pramipexole in patients with Parkinson's disease.Cognitive impairment and dementia in Parkinson's disease: clinical features, diagnosis, and management.A double-blind randomized controlled trial to assess the effect of bright light therapy on depression in patients with Parkinson's disease.The impact of nonmotor symptoms on quality of life in patients with Parkinson's disease in TaiwanParkinson's Disease and Its Management: Part 5: Treatment of Nonmotor Complications.A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson's disease patientsEvaluation and management of the non-motor features of Parkinson's disease.
P2860
Q24186581-1C0A8CFF-46E1-40FA-AF44-C26DC06F6812Q26738349-D4A13EF5-D9C5-4DB0-BC2D-D0A2A65E5D7BQ26767268-C095FCAE-2DEB-4BAC-AE54-EDEB542E48A4Q26786623-F9C31DED-048D-4CF2-8DA4-0645AD7CF216Q27333729-93A0530A-9BFE-400B-8C00-FADC3B3171E0Q28078546-D8476193-397C-44F3-90FD-2B6FC9822663Q30240991-7C741DC5-CAEA-4DEC-9A3E-FCC054292512Q30419918-BA8154D1-5762-49E1-B19E-96AF92793AEDQ33604937-3753C7B9-0C79-4242-9D21-CF7BAAE12044Q33607256-729E6FFC-D1CA-4031-9BF6-A7AF0B32EB7AQ33765388-BCE8282C-5DFF-4DB9-9015-676A7A53DB45Q33917094-F17DFB37-0809-4256-9B9B-57E3BB7D1F19Q33921178-ACC2F3B8-53BF-4ACC-AE5B-E83632314807Q34094065-1ED39399-6DBC-43CC-BA9A-ABD7719A1E20Q34198761-0EE7F3A3-C1FE-4AE2-96C9-525858500A20Q34272602-B0B2CF1F-6E56-4CE0-A79C-694ED03F5E03Q34332812-CE77CEE5-7AE6-4DC8-894B-C3D219257E56Q34382560-0549ACEF-2193-44DD-A9DC-BE9CA98AAD1AQ34388686-E82B8F90-883D-44B8-847B-4804C6F436F5Q34443504-A5E78663-5B0C-4C97-ABAD-D538938A0191Q34464938-9995DAA7-1860-4946-A34D-430963D99D86Q34630735-A05719A1-8991-4A43-820B-70BD22016294Q35009609-25304BAE-0804-4B10-979B-AC6CC1464C83Q35013240-48EC4187-C1E7-42B9-8FB2-03AB85E478FFQ35028706-04F2F125-1B2F-4672-8A08-5E0C5282D0A7Q35043846-2BED58F7-7B5F-44EB-9F92-D7EFD164BD83Q35160241-10DED876-2638-4BC5-B159-FA3EB5171E3CQ35269306-B5FCA6F9-62A8-4FAC-8F46-795F188BF220Q35654026-3B0CE6AB-B8DB-427A-A65B-3458FB91B4FDQ35687306-2E4EC9F2-80C9-4F26-88EA-AEC36C68ED53Q35688126-9907866B-28CE-4309-886A-00DA9B1A4AECQ35823575-BE90B7BA-D0FE-46E4-A42D-39932AB2C00AQ35825918-D27A0953-29A5-4AFE-99AB-3899D9EB36B2Q35837892-59701A02-83A9-4C4A-8FCD-F7A53FBE7BCBQ35988441-11CEADB1-5706-4914-80C2-636851662F39Q36171269-4FA70C35-968D-48D2-BC7A-9203DDA9A66CQ36284387-653EBD0E-80DD-4BBA-906C-2B7A321587C6Q36351543-88D884B9-311F-48F3-9EFA-8D2540BE9D91Q36366224-3E47A5E8-B050-41C0-9CE9-14F2249EBD88Q36443721-A93452C6-6015-4F2C-9E8B-89E87956A30F
P2860
Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pramipexole for the treatment ...... ind, placebo-controlled trial.
@ast
Pramipexole for the treatment ...... ind, placebo-controlled trial.
@en
Pramipexole for the treatment ...... ind, placebo-controlled trial.
@nl
type
label
Pramipexole for the treatment ...... ind, placebo-controlled trial.
@ast
Pramipexole for the treatment ...... ind, placebo-controlled trial.
@en
Pramipexole for the treatment ...... ind, placebo-controlled trial.
@nl
prefLabel
Pramipexole for the treatment ...... ind, placebo-controlled trial.
@ast
Pramipexole for the treatment ...... ind, placebo-controlled trial.
@en
Pramipexole for the treatment ...... ind, placebo-controlled trial.
@nl
P2093
P50
P921
P1433
P1476
Pramipexole for the treatment ...... ind, placebo-controlled trial.
@en
P2093
Catherine Debieuvre
Dan Massey
Stefan Albrecht
P304
P356
10.1016/S1474-4422(10)70106-X
P577
2010-05-07T00:00:00Z